| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥2623.3B | ¥2640.2B | -0.6% |
| Operating Income | ¥377.2B | ¥378.6B | -0.4% |
| Ordinary Income | ¥394.3B | ¥404.0B | -2.4% |
| Net Income | ¥293.4B | ¥286.6B | +2.2% |
| ROE | 10.2% | 10.3% | - |
FY2026 Q3 cumulative results showed revenue of 262.3B yen (YoY -0.6%), operating income of 37.7B yen (YoY -0.4%), ordinary income of 39.4B yen (YoY -2.4%), and net income of 29.3B yen (YoY +2.4%). Performance remained largely flat with minimal revenue decline offset by stable profitability. Operating margin of 14.4% remained solid, though ordinary income declined due to reduced non-operating contributions compared to prior year. Net income growth of 2.4% was supported by extraordinary gains including investment securities sales of 1.7B yen and fixed asset disposals of 1.2B yen. The company maintained its full-year forecast of revenue 348.0B yen, operating income 49.5B yen, and net income 30.6B yen, with dividend per share of 40 yen unchanged.
[Profitability] ROE of 10.0% exceeds the manufacturing industry median of 5.0%, positioning in the upper quartile of peers. Net profit margin of 11.2% significantly outperforms the industry median of 6.3%, while operating margin of 14.4% also exceeds the industry median of 8.3% by 6.1 percentage points. DuPont analysis reveals ROE components of net profit margin 10.9%, total asset turnover 0.705, and financial leverage 1.30x. The asset turnover of 0.705 exceeds the industry median of 0.58, though remains a constraint on ROE potential given the company's substantial cash holdings. [Cash Quality] Cash and deposits totaled 131.2B yen, representing 35.3% of total assets. Short-term debt coverage stands at an exceptional 659.5 times cash-to-short-term-liabilities ratio. Working capital of 194.4B yen provides substantial operational buffer. [Investment Efficiency] Asset turnover of 0.705 surpasses industry median, though improvement potential exists through enhanced receivables and inventory management. Receivables turnover of 72 days exceeds industry median of 82.9 days, indicating relatively efficient collection despite quality alerts. Inventory turnover of 94 days compares favorably to industry median of 108.8 days. [Financial Health] Equity ratio of 77.0% substantially exceeds industry median of 63.8%, ranking among the most conservative capital structures. Current ratio of 468.0% and quick ratio of 416.7% both far exceed industry norms, with current ratio well above the median of 2.84x. Interest-bearing debt of 0.4B yen represents minimal leverage with debt-to-equity ratio of 0.1%, significantly below typical manufacturing companies.
Cash and deposits increased 23.5B yen YoY to 131.2B yen, reflecting continued strong cash accumulation supported by operating profitability. The increase represents 17.9% growth in cash position, substantially ahead of revenue performance, indicating robust cash generation capacity. Working capital totaled 194.4B yen with accounts receivable of 51.8B yen, inventory of 27.1B yen, and accounts payable of 21.8B yen, maintaining efficient operating cycle management. The company reduced investment securities holdings from 0.7B yen to 0.3B yen, a decline of 49.7%, reflecting portfolio rationalization that generated realized gains of 1.7B yen in extraordinary income. Treasury stock increased from 18.6B yen to 26.6B yen in book value terms, representing 42.8% expansion in share repurchases as part of shareholder return enhancement. Net working capital turnover of 271 days positions favorably relative to industry median of 108.1 days, though the extended cycle reflects the company's conservative liquidity management. Cash coverage of total liabilities stands at 1.53 times, providing substantial financial flexibility and minimal refinancing risk despite short-term liabilities representing 50.5% of total liabilities.
Ordinary income of 39.4B yen versus operating income of 37.7B yen shows net non-operating contribution of approximately 1.7B yen, comprising primarily interest income of 1.0B yen and foreign exchange gains of 0.8B yen. Non-operating income represents 0.7% of revenue, indicating limited dependency on financial income with core profitability driven by operations. Extraordinary gains totaled 2.9B yen including investment securities sales of 1.7B yen and fixed asset disposals of 1.2B yen, contributing meaningfully to net income of 29.3B yen. These one-time items represent approximately 9.9% of net income, warranting attention to underlying recurring earnings power. The effective tax rate of 26.8% remains within normal range. While operating cash flow data is unavailable for quarterly reporting, balance sheet analysis indicates healthy cash generation with cash increasing 23.5B yen YoY outpacing net income growth, suggesting positive cash conversion. The substantial cash accumulation relative to net income implies operating cash flow exceeds reported earnings, supporting earnings quality assessment despite one-time gain contributions to bottom line.
Receivables collection extends to 72 days, triggering quality monitoring alerts for potential working capital pressure. While below industry median, any further deterioration could constrain cash conversion and liquidity despite current strong cash position. Foreign exchange volatility presents ongoing risk with FX gains of 0.8B yen contributing to current period results; reversal of currency trends could pressure non-operating income and ordinary profit levels. Short-term liabilities ratio of 50.5% exceeds the 40% threshold, indicating elevated refinancing concentration risk. Although current cash holdings of 131.2B yen provide 659.5 times coverage of short-term debt, the liability maturity structure warrants monitoring to ensure continued funding flexibility.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: ROE 10.0% substantially exceeds manufacturing industry median of 5.0%, ranking in upper quartile. Operating margin of 14.4% outperforms industry median of 8.3% by 6.1 percentage points. Net profit margin of 11.2% versus industry median of 6.3% demonstrates superior earnings conversion.
Financial Health: Equity ratio of 77.0% significantly exceeds industry median of 63.8%, reflecting conservative capitalization. Current ratio of 468.0% far surpasses industry median of 2.84x, indicating exceptional liquidity strength. Minimal debt leverage contrasts with typical industry practice.
Efficiency: Asset turnover of 0.705 exceeds industry median of 0.58, though reflects high cash holdings. Receivables turnover of 72 days compares favorably to industry median of 82.9 days. Inventory turnover of 94 days outperforms industry median of 108.8 days by 13.7%.
Growth: Revenue decline of 0.6% underperforms industry median growth of 2.7%. EPS growth performance positions below industry median, though absolute profitability metrics remain superior.
(Industry: Manufacturing, N=98 companies, Comparison: FY2025-Q3 period, Source: Proprietary analysis)
Nifco demonstrates superior profitability metrics with ROE of 10.0% and operating margin of 14.4% both substantially exceeding manufacturing industry medians, supported by strong operational efficiency in receivables and inventory management. The company maintains fortress-like financial health with equity ratio of 77.0%, minimal debt of 0.4B yen, and exceptional liquidity of 131.2B yen cash, positioning it in the top tier of financial stability among manufacturing peers. Capital allocation strategy shows meaningful shift with treasury stock increasing 42.8% to 26.6B yen and investment securities declining 49.7%, indicating enhanced shareholder returns through buybacks and portfolio optimization that generated 1.7B yen in realized gains. Revenue stagnation of negative 0.6% YoY versus industry median growth of positive 2.7% represents key concern, though profit margins remain resilient and full-year guidance maintained, suggesting stable demand in core industrial plastic components segment despite macroeconomic headwinds.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.